| Mrs Helene Margareta Mansfield, RN, MN | |
|
301 21st Ave E, Seattle, WA 98112-5318 | |
| (206) 252-2200 | |
| Not Available |
| Full Name | Mrs Helene Margareta Mansfield |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 301 21st Ave E, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003154832 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 00118674 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Helene Margareta Mansfield, RN, MN 301 21st Ave E, Seattle, WA 98112-5318 Ph: (206) 252-2200 | Mrs Helene Margareta Mansfield, RN, MN 301 21st Ave E, Seattle, WA 98112-5318 Ph: (206) 252-2200 |
News Archive
The co-authors are employees of the Protein-Cell Interactions Lab of Kazan Federal University (Natalia G. Evtugina, Alina D. Peshkova, and Lab Head Rustem I. Litvinov) in cooperation with Interregional Clinical Diagnostic Center, Kazan, Russia (Arseniy A. Pichugin) and University of Pennsylvania (John W. Weisel and Rustem I. Litvinov by his primary employment).
Medical school students receive little formal instruction in radiation oncology, a Loyola study has found.
Results from a phase 2 clinical trial, presented by Seattle Children's Research Institute at the 59th American Society of Hematology Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft-versus-host disease (GvHD) in patients receiving hematopoietic stem cell transplants.
Mirth, LLC, a wholly owned subsidiary of Quality Systems, Inc. and a global leader in health information technology, announced today that Mirth® Connect version 3.0.1 is compliant with the ONC 2014 Edition criteria and was certified as an Electronic Health Record (EHR) Module on May 1, 2014 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ACB, in accordance with the applicable Eligible Providers (Ambulatory) certification criteria adopted by the Secretary of Health and Human Services.
ev3 Inc. today announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multi-center, single-arm study evaluating the EverFlex® Self-Expanding Stent System for the treatment of superficial femoral artery (SFA) and proximal popliteal lesions. The DURABILITY II study will support a planned Premarket Approval (PMA) filing with the U.S. Food and Drug Administration to obtain approval of the EverFlex Self-Expanding Stent System for use in the SFA.
› Verified 1 days ago
Eileen Bullinger, RN, MS Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1915 1st Ave W, Seattle, WA 98119 Phone: 206-252-1900 Fax: 206-252-1901 | |
Andrea Barrett-hollander, CNM Registered Nurse Medicare: Medicare Enrolled Practice Location: 5350 Tallman Ave Nw Ste 420, Seattle, WA 98107 Phone: 206-781-6161 Fax: 206-781-6208 | |
Liane Mf Richter, ARNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 123 Broadway E, Seattle, WA 98102 Phone: 206-465-0316 | |
Julie Ann Crassweller, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 9934 8th Ave Sw, Seattle, WA 98106 Phone: 206-477-0044 | |
Anne Magnuson Roberts, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2124 4th Ave, Seattle, WA 98121 Phone: 206-263-8685 | |
Eric Sailor, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2600 Sw Holden St, Seattle, WA 98126 Phone: 206-933-7200 |